GLSI
Greenwich LifeSciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
The constructive case is that FLAMINGO-01 operational momentum is improving: FDA cleared use of the first commercial GP2 lot, screening rose above 800 patients per year, the 250-patient open-label arm is fully enrolled, and company-reported early recurrence trends remain favorable versus historical benchmarks [#PR-2026-01-22] [#PR-2026-03-03] [#PR-2026-03-17].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +20.4.
What can break
Going-concern and dilution risk remain material despite January 2026 ATM progress [#10-Q-2025-11-14] [#PR-2026-01-27].
Momentum
4
Value
41
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $40.00 · Bear $12.00
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $57.00
Why
Momentum4 · Δ7d -1.5
Value41 · Δ7d -0.0
Sentiment100 · Δ7d +20.4
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
4
26% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
-19.3
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.1
Sentiment
100
34% active weight
Current posture
7d trendImproving
Δ7d
+20.4
Δ21d
+44.6
Why this grade
Composite grade C. Momentum 3.6 / Value 41.1 / Sentiment 100.0
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$215.04M
Beta
1.45
Shares Out
14.68M
P/E (TTM) · Derived
-10.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-16.14
Rev YoY
-
EPS YoY
+86.4%
Gross Margin
-
Op Margin
-
Net Debt
-$6.18M
Current Ratio
2.01
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology

